Home » Qatar Venture Capital »

|| Qatar investors acquired stake in US cancer treatment firm for $40 million

qia-oncoQatar investors of Qatar Investment Authority (QIA), and some other venture capital firms invested $40 million in OncoResponse, a healthcare company developing antibodies for the treatment of cancer.

Established in 2015 and based in Houston Texas, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies that will lead to the development of therapeutics for treatment of cancer. (QIA was established in 2005. Headquartered in Doha, it was founded as a means to strengthen the country's economy. the fund predominantly invests in international markets United States, Europe and Asia-Pacific and within Qatar outside the energy sector.) More details here.

Qatar Investment Authority is listed in the Middle East Investors Directory with the code BD44.

Previous Post: Saudi investors of PIF to invest $1 billion in US car maker Lucid
Next Post: Saudi Arabian firm acquired Ukrainian farming company Mriya

More from Qatar Venture Capital ...

  Qatar investors acquired stake in US cancer treatment firm for $40 million

  Qatar investment firm purchased Beverly Hills office building for $177 million

  Qatar firm QSTEC acquired 49% of German solar company SolarWorld

  Qatar private equity firm QInvest acquired asset management firm Portfoy

  Qatar private equity firm QInvest acquired 16 property retail portfolio in Germany

|| About Us

Established in 2007, DubaiBeat.com provides insight, analysis and research on Middle East investors.

We cover different asset class investors like private equity, venture capital, hedge funds and real estate investors from the Middle East and broader MENA region.

|| Subscribe

Copyright 2007-2021 DubaiBeat.com    Sitemap  |  Terms  |  Privacy Policy

Follow us: RSS Feed   Facebook    Twitter